New listings for opioid medications on the Palliative Care Schedule for the management of severe disabling pain from 1 June 2021
Page last updated: 21 May 2021
Commencing 1 June 2021, the Palliative Care Schedule (PCS) will include new and amended listings for opioid medications.
Following consideration of the Department of Health commissioned review of the PCS, the Pharmaceutical Benefits Advisory Committee has recommended the inclusion of additional formulations of fentanyl, hydromorphone, methadone and morphine on PCS, and the addition of new listings for oxycodone and oxycodone with naloxone modified release products.
These changes reflect the PBAC’s recommendations and are intended to further reduce barriers to the prescribing and timely supply of opioid analgesic medications for palliative care patients.
For more information, please click on the link below: